Customized research for MLNT vs. NBRV!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for MLNT vs. NBRV.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Melinta Therapeutics Inc. vs. Nabriva Therapeutics AG

Industry Match! Industry of Both MLNT and NBRV:

Health Care/Life Sciences

MLNT
Data Last Updated: More than 6 mos ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 6.875M


P/E: N/A

P/S: 0.07

Q P/B: N/A

Y Rev: 96.43M

Q Rev: 15.87M

Beta: 6.44

MLNT Share Stats

Outstanding Shares

11.78M

Float Shares

10.37M

Percent of Float Short

20.95%

MLNT Insider Stats

Percent Outstanding Insider Ownership

8.55%

Percent Outstanding Institution Ownership

24.45%

MLNT Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

MLNT in Pulse Portal

Stream of Posts

MLNT Symbol Page

Share MLNT Insights

Express Sentiment

'Buy' or 'Sell' MLNT

MLNT Profile

CEO

Ms. Jennifer A. Sanfilippo

Exchange

Nasdaq

Employees

290.00

About

Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv,...

MLNT Financials

Annual Financials

Income Statement

Revenue

96.43M

Net Income

(157.19M)

Cash Flow Statement

Change in Cash / Investments

(46.58M)

Balance Sheet

Cash / Investments

81.81M

Short Term Debt

None

Long Term Debt

110.48M

Total Current Assets

149.48M

Total Current Liabilities

133.61M

Total Assets

441.59M

Total Liabilities

251.53M

Stockholder Equity

190.06M

Quarterly Financials

Income Statement

Q Revenue

15.87M

Q Net Income

(213.38M)

Cash Flow Statement

Q Change in Cash / Investments

(26.82M)

Balance Sheet

Q Cash / Investments

63.52M

Q Short Term Debt

7.82M

Q Long Term Debt

152.79M

Q Total Current Assets

131.27M

Q Total Current Liabilities

128.05M

Q Total Assets

228.49M

Q Total Liabilities

289.02M

Q Stockholder Equity

(60.53M)

MLNT Charts

10-Year Chart

MLNT 10-Year Chart

5-Year Chart

MLNT 5-Year Chart

1-Year Chart

MLNT 1-Year Chart

6-Month Chart

MLNT 6-Month Chart

3-Month Chart

MLNT 3-Month Chart

1-Month Chart

MLNT 1-Month Chart

1-Day Chart

MLNT 1-Day Chart

NBRV
Data Last Updated: 6 days ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 110.941M


P/E: N/A

P/S: 11.7

Q P/B: 5.57

Y Rev: 9.48M

Q Rev: 789,000

Beta: 2.50

NBRV Share Stats

Outstanding Shares

142.97M

Float Shares

131.43M

Percent of Float Short

4.05%

NBRV Insider Stats

Percent Outstanding Insider Ownership

2.32%

Percent Outstanding Institution Ownership

41.25%

NBRV Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

NBRV in Pulse Portal

Stream of Posts

NBRV Symbol Page

Share NBRV Insights

Express Sentiment

'Buy' or 'Sell' NBRV

NBRV Profile

CEO

Dr. Steven P. Gelone

Exchange

Nasdaq

Employees

162.00

About

Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the research, development and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, and CONTEPO. The company was founded in October...

NBRV Financials

Annual Financials

Income Statement

Revenue

9.48M

Net Income

(82.76M)

Cash Flow Statement

Change in Cash / Investments

(15.59M)

Balance Sheet

Cash / Investments

86.59M

Short Term Debt

None

Long Term Debt

34.5M

Total Current Assets

91.17M

Total Current Liabilities

16.64M

Total Assets

94.11M

Total Liabilities

52.84M

Stockholder Equity

41.27M

Quarterly Financials

Income Statement

Q Revenue

789,000

Q Net Income

(23.26M)

Cash Flow Statement

Q Change in Cash / Investments

(59.08M)

Balance Sheet

Q Cash / Investments

27.56M

Q Short Term Debt

None

Q Long Term Debt

7.37M

Q Total Current Assets

38.17M

Q Total Current Liabilities

11.96M

Q Total Assets

41M

Q Total Liabilities

21.09M

Q Stockholder Equity

19.91M

NBRV Charts

10-Year Chart

NBRV 10-Year Chart

5-Year Chart

NBRV 5-Year Chart

1-Year Chart

NBRV 1-Year Chart

6-Month Chart

NBRV 6-Month Chart

3-Month Chart

NBRV 3-Month Chart

1-Month Chart

NBRV 1-Month Chart

1-Day Chart

NBRV 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon